Migraine
Authors: Christine Laine
Journal: Annals of Internal Medicine (2007)

In the Clinic6 November 2007MigraineChristine Laine, MD, MPH, David R. Goldman, MD, and Jennifer F. WilsonChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, and Jennifer F. WilsonSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-147-9-200711060-01011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.DiagnosisMigraine headache affects 18% of women and 6% of men. Three quarters of migraine sufferers have moderate-to-severe symptoms that interfere with work, school, and other normal daily activities. Despite being a significant cause of episodic but disabling symptoms, the condition remains underrecognized, underdiagnosed, and undertreated. Migraine pain was previously believed to be largely vascular in cause, but evidence now shows that it involves genetic control of the activity of some brain cells. It is hypothesized that migraine activity begins in the brainstem and ends with distention and ...References1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160. [PMID: 14979299] Google Scholar2. Michel P, Dartigues JF, Henry P, et al. Validity of the International Headache Society criteria for migraine. GRIM. Groupe de Recherche Interdisciplinaire sur la Migraine. Neuroepidemiology. 1993;12:51-7. [PMID: 8327023] Google Scholar3. ID Migraine validation study. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61:375-82. [PMID: 12913201] Google Scholar4. Frishberg BM. The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology. 1994;44:1191-7. [PMID: 8035914] Google Scholar5. Detsky ME, McDonald DR, BarelocherMO, et al. Does thsi patients with a headache have migarine or need neuroimaging?JAMA. 2006;296:1274-83. [PMID: 16968852] Google Scholar6. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 978;88:162-7. [PMID: 626444] Google Scholar7. Rodriguez-Valverde V, Sarabia JM, et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997;102:331-6. [PMID: 9217613] Google Scholar8. Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature. Neurology. 1995;45:1263-7. [PMID: 7617180] Google Scholar9. Peatfield RC. Relationships between food, wine, and beer-precipitated migrainous headaches. Headache. 1995;35:355-7. [PMID: 7635722] Google Scholar10. Van den Bergh V, Amery WK, Waelkens J. Trigger factors in migraine: a study conducted by the Belgian Migraine Society. Headache. 1987;27:191-6. [PMID: 3597073] Google Scholar11. Lipton RB, Newman LC, Cohen JS, Solomon S. Aspartame as a dietary trigger of headache. Headache. 1989;29:90-2. [PMID: 2708042] Google Scholar12. Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet. 1983;2:865-9. [PMID: 6137694] Google Scholar13. Mansfield LE, Vaughan TR, Waller SF, Haverly RW, Ting S. Food allergy and adult migraine: double-blind and mediator confirmation of an allergic etiology. Ann Allergy. 1985;55:126-9. [PMID: 4025956] Google Scholar14. Kueper T, Martinelli D, Konetzki W, et al. Identification of problem foods using food and symptom diaries. Otolaryngol Head Neck Surg. 1995;112:415-20. [PMID: 7870442] Google Scholar15. Guarnieri P, Radnitz CL, Blanchard EB. Assessment of dietary risk factors in chronic headache. Biofeedback Self Regul. 1990;15:15-25. [PMID: 2361144] Google Scholar16. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain. 1990;42:1-13. [PMID: 2146583] Google Scholar17. Bronfort G, Nilsson N, Haas M, et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev. 2004; CD001878. [PMID: 15266458] Google Scholar18. Goslin RE, Gray RN, McCrory DC, et al. Behavioral and physical treatments for migraine headache. Technical review 2.2. Agency for Health Care Policy and Research; 1999. AHCPR no. 290-94-2025. Google Scholar19. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123 (Pt 8):1703-9. [PMID: 10908199] Google Scholar20. Lipton RB, Baggish JS, Stewart WF, et al. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med. 2000;160:3486-92. [PMID: 11112243] Google Scholar21. Lipton RB, Goldstein J, Baggish JS, et al. Aspirin is efficacious for the treatment of acute migraine. Headache. 2005;45:283-92. [PMID: 15836564] Google Scholar22. Goldstein J, Hoffman HD, Armellino JJ, et al. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia. 1999;19:684-91. [PMID: 10524663] Google Scholar23. Disability in Strategies of Care Study group. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA. 2000;284:2599-605. [PMID: 11086366] Google Scholar24. Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia. 1998;18:532-8. [PMID: 9827244] Google Scholar25. Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358: 1668-75. [PMID: 11728541] Google Scholar26. Oldman AD, Smith LA, McQuay HJ, et al. Pharmacological treatments for acute migraine: quantitative systematic review. Pain. 2002;97:247-57. [PMID: 12044621] Google Scholar27. Winner P, Ricalde O, Le Force B, et al. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53:180-4. [PMID: 8639069] Google Scholar28. Colman I, Brown MD, Innes GD, et al. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med. 2005;45:393-401. [PMID: 15795718] Google Scholar29. Bigal ME, Lipton RB, Krymchantowski AV. The medical management of migraine. Am J Ther. 2004;11:130-40. [PMID: 14999365] Google Scholar30. Tfelt-Hansen P, Saxena PR, Dahlöf C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000;123 ( Pt 1):9-18. [PMID: 10611116] Google Scholar31. Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329:1369-73. [PMID: 15550401] Google Scholar32. Holroyd KA, Cordingley GE, Pingel JD, et al. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Headache. 1989;29:148-53. [PMID: 2496052] Google Scholar33. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache. 1991;31:333-40. [PMID: 1830566] Google Scholar34. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004:CD003225. [PMID: 15106196] Google Scholar35. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev. 2004:CD003226. [PMID: 15266476] Google Scholar36. Gray RN, Goslin RE, McCrory DC, et al. Drug treatments for the prevention of migraine headache. Technical review 2.3. Agency for Health Care Policy and Research; 1999. ACHPR no. 290-94-2025. Google Scholar37. Silberstein SD, Elkind AH, Schreiber C, et al. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-9. [PMID: 15277618] Google Scholar38. Göbel H. Botulinum toxin in migraine prophylaxis. J Neurol. 2004;251 Suppl 1:I8-11. [PMID: 14991336] Google Scholar39. Holroyd KA, France JL, Cordingley GE, Rokicki LA, Kvaal SA, Lipchik GL, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol. 1995;63:327-30. [PMID: 7751496] Google Scholar40. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 1990;30:334-9. [PMID: 2370132] Google Scholar41. Gallagher RM. Emergency treatment of intractable migraine. Headache. 1986;26:74-5. [PMID: 3957657] Google Scholar42. Penzien DB, Johnson CA, Seville J, et al. Interrelationships among daily and global self-report measures of headache. Headache Q. 1994;5:8-14.84 Google Scholar43. Kurth T, Gazian JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283-91. [PMID: 16849661] Google Scholar44. Kurth T, Gazian JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med. 2007;167:795-801. [PMID: 17452542] Google Scholar45. Saper JR, Lake AE , Madden SF, et al. Comprehensive/Tertiary care for headache: a 6-month outcome study. Headache. 1999;39:249-63. [PMID: 15613222] Google Scholar46. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-62. [PMID: 10993991] Google Scholar47. Snow V, Weiss K, Wall EM, et al. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840-9. [PMID: 12435222] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCorrection: In the Clinic: Migraine Metrics Cited byThe Role of Cardiovascular Screening in Headache Patients 6 November 2007Volume 147, Issue 9Page: ITC11-1KeywordsAnalgesicsDrug therapyDrugsEpilepsyFoodHeadachesMigraineNauseaSystematic reviewsVomiting ePublished: 6 November 2007 Issue Published: 6 November 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...